Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Thirty-day readmission after status epilepticus in the United States: Insights from the nationwide readmission database

Epilepsy Research(2020)10.1016/j.eplepsyres.2020.106346Source: DataRank Database

Thirty-day readmission after status epilepticus in the United States: Insights from the nationwide readmission database is a research paper published in Epilepsy Research (2020). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

4 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.43)OA: closedTopics (34)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

David J. Thurman ORCID,Hiba A. Haider ORCID,Andrés Rodríguez ORCID,Nathalie Jetté ORCID,Edward Faught

Live enrichment

PubMed:32521438 OpenAlex:https://openalex.org/W3027104318

National Institutes of Health

Grant: IU54NS100064

National Institutes of Health

Grant: U24NS107201

National Institutes of Health

Grant: 5RO1NS088748-05

Patient-Centered Outcomes Research Institute

Eisai

National Institute of Neurological Disorders and Stroke

FWCI

0.43

Citation Percentile

0.6%

Citation Trend

2022

2023

2024

closedLicense: https://www.elsevier.com/legal/tdmrep-license

publisherhttps://api.elsevier.com/content/article/PII:S0920121120300590?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0920121120300590?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.eplepsyres.2020.106346

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32521438

Fields of Study

Epilepsy research and treatmentPharmacological Effects and Toxicity StudiesHeart Failure Treatment and Management

MeSH Terms

AdultAgedFemaleHumansLength of StayMaleMiddle AgedPatient DischargePatient ReadmissionPostoperative ComplicationsRisk FactorsTime Factors

Keywords

MedicineInterquartile rangeOdds ratioConfidence intervalKidney diseaseDiabetes mellitusIncidence (geometry)Internal medicinePopulationStatus epilepticusDiagnosis codeLogistic regressionComorbidityPediatricsEmergency medicineEpilepsyPsychiatrySeizureReadmissions

Sustainable Development Goals

SDG 0: Good health and well-being